Related Experiment Videos
[The soluble IL-2 receptor in malignant hemopathies]
S Rupoli1, M Montillo, A Salvi
1Istituto di Clinica medica generale e Terapia medica, Clinica di Ematologia, Università, Ancona.
Recenti Progressi in Medicina
|October 1, 1992
Summary
Soluble IL-2 receptor (sIL-2R) levels aid in diagnosing and monitoring various blood cancers. Elevated sIL-2R is significant in hairy cell leukemia and Hodgkin
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Soluble interleukin-2 receptor (sIL-2R) is released from activated or neoplastic cells.
- Elevated sIL-2R levels are observed in various hematologic malignancies.
Purpose of the Study:
- To investigate the diagnostic, prognostic, and physiopathologic significance of sIL-2R in hematologic patients.
- To assess sIL-2R levels across different stages and types of hematologic diseases.
Main Methods:
- Serum samples from 271 hematologic patients were analyzed for sIL-2R levels.
- Correlations between sIL-2R levels and disease characteristics were examined.
Main Results:
- Elevated sIL-2R has diagnostic value in Hairy Cell Leukemia (HCL).
- sIL-2R levels correlate with disease extent in Hodgkin's Disease (HD) and are crucial for monitoring HCL, NHL, HD, AL, and MDS.
- Multiple Myeloma shows only slight sIL-2R elevations, irrespective of stage.
- Chronic myeloproliferative disorders like ET and PV have slightly elevated values, while CML and MFI show significant increases during active phases.
Conclusions:
- sIL-2R serves as a valuable biomarker in diagnosing and monitoring several hematologic malignancies.
- Its utility varies across different hematologic disorders, with notable significance in HCL and HD.
- Further research may elucidate specific roles in other conditions like Multiple Myeloma and myeloproliferative disorders.